Bpifrance SA - Q4 2018 holdings

$782 Million is the total value of Bpifrance SA's 9 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was - .

 Value Shares↓ Weighting
FTI NewTECHNIPFMC PLC$498,940,00024,688,691
+100.0%
63.77%
CSTM NewCONSTELLIUM NVcl a$114,593,00016,393,903
+100.0%
14.65%
TLND NewTALEND S Aads$78,346,0002,112,895
+100.0%
10.01%
CRTO NewCRITEO S Aspons ads$61,770,0002,718,752
+100.0%
7.90%
SQNS NewSEQUANS COMMUNICATIONS S Aspons ads$9,427,00012,085,561
+100.0%
1.20%
MLND NewMILLENDO THERAPEUTICS INC$8,575,0001,078,670
+100.0%
1.10%
DBVT NewDBV TECHNOLOGIES S Asponsored adr$5,348,000833,042
+100.0%
0.68%
MITK NewMITEK SKS INC$2,756,000254,941
+100.0%
0.35%
ADVM NewADVERUM BIOTECHNOLOGIES INC$2,609,000828,262
+100.0%
0.33%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CRITEO S A20Q3 202310.1%
TECHNIPFMC PLC13Q4 202168.1%
STELLANTIS NV11Q3 202390.9%
CONSTELLIUM NV11Q2 202141.6%
SEQUANS COMMUNICATIONS S A11Q2 20215.8%
CELLECTIS S.A.10Q2 20232.3%
CONSTELLIUM NV9Q3 20238.3%
SEQUANSCOMMUNICATIONS S A9Q3 20230.5%
MILLENDO THERAPEUTICS INC8Q3 20201.8%
VECTIVBIO HOLDING AG8Q1 20230.8%

View Bpifrance SA's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-07
13F-HR2023-11-13
13F-HR2023-07-28
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-11
13F-HR2022-05-16
13F-HR2022-02-11
13F-HR2021-11-15

View Bpifrance SA's complete filings history.

Compare quarters

Export Bpifrance SA's holdings